ARCHIVES

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Management Director Leaving For Case Institute.

October 12, 2001

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

Hamburg Confirmed As FDA Commissioner

May 22, 2009